Nano-uhplc orbitrap MS-LC system-autosampler service

Active Awarded Last action

Contract number
75F40125F80052
Awardee
Awarding agency
Obligated
$131,765

Award facts

Contract value 48% obligated
  • $131,764.53 Current, with exercised options
  • $277,034.91 Potential, with all options
Completion date 35% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
561210 Facilities Support Services
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Charlotte, NC 28277, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00002 $67,489
Other Administrative Action P00001 $0
Original award $64,275

About this award

The Food and Drug Administration awarded a delivery order valued at $277,034.91 to The Remi Group LLC for nano-UHPLC (ultra-high-performance liquid chromatography) Orbitrap mass spectrometry-liquid chromatography system maintenance and autosampler service support. The delivery order, issued May 20, 2025, with an ultimate completion date of May 20, 2029, operates under a firm fixed-price structure with no small business set-aside designation. Services will be performed at the contractor's Charlotte, North Carolina location. This delivery order is issued under The Remi Group's General Services Administration Multiple Award Schedule contract vehicle, which enables federal agencies to procure equipment maintenance services at pre-negotiated rates.

The Remi Group LLC, a Charlotte-based Subchapter S corporation registered in SAM.gov since 2008, specializes in comprehensive maintenance, repair, and technical support for sophisticated laboratory and scientific instrumentation across federal agencies. The company holds two significant Indefinite Delivery/Indefinite Quantity blanket purchase agreements totaling more than $59.5 million in cumulative potential value—a $10 million Department of Veterans Affairs BPA and a $49.6 million Centers for Disease Control and Prevention BPA—positioning it to deliver responsive equipment maintenance support across the federal government's scientific research infrastructure. The Remi Group's extensive federal contracting history spans virtually all major civilian research and healthcare agencies, including the National Institutes of Health, USDA, EPA, and DoD components.

Quick answers

Who was awarded contract 75F40125F80052?

75F40125F80052 was awarded to The Remi Group LLC by Food and Drug Administration (Department of Health and Human Services) on May 20, 2025.

How much is contract 75F40125F80052 worth?

The government has obligated $131,765 on 75F40125F80052. Its potential value, with all options, is $277,035.

Is contract 75F40125F80052 an order under another contract?

Yes. 75F40125F80052 is a delivery order under GS21F0093V, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40125F80052 competed?

The extent of competition for 75F40125F80052 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award